Company Filing History:
Years Active: 1993-1997
Title: Innovations of Emerald Martin Spencer
Introduction
Emerald Martin Spencer is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic applications involving human somatomedin carrier proteins. With a total of four patents to his name, Spencer's work has the potential to impact various medical and therapeutic practices.
Latest Patents
One of Spencer's latest patents focuses on the therapeutic uses of human somatomedin carrier proteins. This invention relates to polypeptides that are human somatomedin carrier protein subunits and to processes for producing them. The carrier protein subunits bind to human somatomedin-like polypeptides, also known as insulin-like growth factors. The process involves preparation from a human serum fraction, Cohn IV-1, through various chromatographic steps. Additionally, this invention encompasses DNA molecules encoding human somatomedin carrier protein-like polypeptides, recombinant DNA molecules, hosts, and processes for producing these carrier protein-like polypeptides. The invention also includes methods for producing human somatomedin carrier protein-like polypeptides using recombinant technology, which can be utilized in a variety of therapeutic, diagnostic, and other applications.
Career Highlights
Emerald Martin Spencer is currently associated with Celtrix Pharmaceuticals, Inc., where he continues to innovate and develop new therapeutic solutions. His work at Celtrix has allowed him to explore the potential of human somatomedin carrier proteins in various medical applications.
Collaborations
Spencer collaborates with Carol Talkington-Verser, who is also a key figure in his research endeavors. Their partnership exemplifies the collaborative spirit often found in the field of biotechnology.
Conclusion
Emerald Martin Spencer's contributions to the field of biotechnology through his patents and collaborations highlight his commitment to advancing therapeutic applications. His work has the potential to lead to significant advancements in medical science.